miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discovering and developing innovative microRNA-targeting therapies to improve human health. At miRagen Therapeutics we leverage in-house expertise in microRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class microRNA-based technologies and high-potential drug candidates. We have developed ongoing, collaborative relationships with academic institutions that give us unique access to promising early-stage discoveries. This access to groundbreaking science provides a significant strategic advantage in the rapidly-developing field of microRNA-targeting therapeutics. Our microRNA development platform serves as the foundation for a diversified pipeline. Our therapeutic areas of focus include cancer, pathologic fibrosis, neuro-inflammatory, and cardiovascular diseases. Source
No articles found.
Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...
Immuron Ltd is a publicly listed Australian bio...
Agenus is an immuno-oncology company designed to deliver innovation with speed for...
Agenus is an immuno-oncology company designed t...
TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed...
TherapeuticsMD, Inc. is an innovative pharmaceu...
Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focu...
Paratek Pharmaceuticals, Inc. is a commercial-s...
UroGen Pharma Ltd. is a clinical-stage biopharmaceutical company developing advanc...
UroGen Pharma Ltd. is a clinical-stage biopharm...
Stoke is pioneering a new way to treat the underlying cause of severe genetic dise...
Stoke is pioneering a new way to treat the unde...
Atlantica is a total return sustainable infrastructure company that owns, manages ...
Atlantica is a total return sustainable infrast...
Join the National Investor Network and get the latest information with your interests in mind.